Win More Botox & Filler Bookings — AI Marketing for Derby Aesthetic Clinics.

We build a dedicated engineering-partner funnel separate from the general aesthetic funnel. The landing page is structured around partner-of-engineering-professional positioning, Sinfin/Burnaston/Litchurch proximity messaging, evening and Saturday booking availability accommodating engineering work schedules, multi-area package pricing aligned with the demographic's spend pattern, and clinical-credential-led messaging that resonates with technically-literate households. Google Ads target households in DE22, DE3, DE23 and the wider engineering catchment with creative emphasising naturalism, professional discretion and named-prescriber GPhC/BACN/JCCP credentials rather than overt social-led aesthetic messaging. Derby clinics running this typically lift engineering-partner bookings 50–80% within 90 days at premium ticket sizes — engineering-partner patients are particularly loyal once captured.

Derby's geographic proximity to Nottingham (30 minutes via A52) means Derby patients are constantly within reach of West Bridgford Sk:n, Transform and Therapie marketing. Defending requires strong Derby-specific signal: DE-postcode-specific Google Business Profile optimisation, DE-postcode review velocity (60–100 DE-postcode-specific 5-star reviews stacked over 12 months that Nottingham clinic profiles cannot match in Derby search results), named-prescriber E-E-A-T (GPhC, BACN, JCCP, indemnity), and creative that explicitly speaks to Derby rather than generic East Midlands. We also build outbound retargeting to Nottingham-aesthetic-search audiences who live in DE postcodes — recapturing patients before they cross the A52.

Yes — Derby is structurally one of the more defensible regional UK markets because chain saturation is very low locally (most chains under-serve Derby in favour of Nottingham/Birmingham), and DE-postcode review velocity stacked over time creates a moat. Independents win on hyperlocal long-tail ('Botox near Allestree', 'lip filler Mickleover', 'tear trough filler Darley Abbey'), named-prescriber E-E-A-T (GPhC, BACN, JCCP, indemnity), and review velocity stacked at DE22/DE3/DE23. We rebuild around 15–25 procedure × neighbourhood landing pages within MHRA/ASA constraints, defend Allestree premium through credentials messaging, build engineering-partner-targeted creative, and route Instagram DMs into AI follow-up. Derby independents using this approach consistently outperform out-of-area chain spend 2.5–4x ROAS.

Every creative is reviewed against CAP Code Section 12, the MHRA prohibition on advertising prescription-only medicines (no consumer-facing 'Botox', 'Bocouture', 'Azzalure' or 'Dysport' — only clinical-context content where law permits), and JCCP/BACN advertising guidance. We avoid 'best', 'guaranteed' and price-led injectable promotions, never run before/after without informed consent and CAP-compliant disclaimers, and gate POM mentions behind consultation flows. Derby-specific note: the engineering-professional patient base is unusually compliance-aware and clinical-credential-driven, and clinics surfacing JCCP/BACN/GPhC compliance prominently in their creative tend to convert that segment 2–3x better than generic competitors. We also pre-empt the JCCP licensing rollout coming in 2025–2026.